On the heels of its decision more than a year ago to pull the plug on tobacco products and rebrand the company as CVS Health, executives are working to give its stores a health and beauty makeover. Rolling out this year to roughly 500 locations across the country, the new store format reflects the company's broader commitment to health care and aims to deliver on what customers have come to expect from its pharmacy locations ― a stronger presentation in core OTC and beauty. For a first-hand look, DSNTV recently met with CVS Health's store leadership team ― including Helena Foulkes, EVP of CVS Health and president of CVS/pharmacy; Judy Sansone, SVP front store business; Alex Perez-Tenessa, VP beauty and personal care; and Cia Tucci, VP store brands ― in New York City to walk through one of the new stores and learn more about the big changes unfolding in the aisles.
The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics.
Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.
Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.
The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance.
Sandoz has launched Glatopa, the first U.S. generic of Teva’s Copaxone (glatiramer acetate injection, 20-mg/ml ), a once-daily treatment for multiple sclerosis.
Eisai announced Monday that the Food and Drug Administration had given Fycompa approval to be used as an adjunctive therapy in treating primary generalized tonic-clonic seizures.
Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength.
Acura Pharmaceuticals and Bayer Healthcare are partnering to develop a product with pseudoephedrine that would be resistant to being used in methamphetamine.
Diplomat Pharmacy announced Friday that it had acquired the Pennsylvania-based Burman’s Specialty Pharmacy, which will expand Diplomat’s hepatitis C specialty services.